AR222478A1 - Un procedimiento para la preparacion de derivados de acetiloximetil-amonio cuaternario sustituidos - Google Patents

Un procedimiento para la preparacion de derivados de acetiloximetil-amonio cuaternario sustituidos

Info

Publication number
AR222478A1
AR222478A1 AR274836A AR27483678A AR222478A1 AR 222478 A1 AR222478 A1 AR 222478A1 AR 274836 A AR274836 A AR 274836A AR 27483678 A AR27483678 A AR 27483678A AR 222478 A1 AR222478 A1 AR 222478A1
Authority
AR
Argentina
Prior art keywords
amethyl
derivatives
procedure
preparation
substituted quaternary
Prior art date
Application number
AR274836A
Other languages
English (en)
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of AR222478A1 publication Critical patent/AR222478A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR274836A 1977-12-16 1978-12-15 Un procedimiento para la preparacion de derivados de acetiloximetil-amonio cuaternario sustituidos AR222478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (1)

Publication Number Publication Date
AR222478A1 true AR222478A1 (es) 1981-05-29

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
AR274836A AR222478A1 (es) 1977-12-16 1978-12-15 Un procedimiento para la preparacion de derivados de acetiloximetil-amonio cuaternario sustituidos

Country Status (15)

Country Link
JP (1) JPS5498711A (es)
AR (1) AR222478A1 (es)
AT (1) AT366380B (es)
AU (1) AU531835B2 (es)
CA (1) CA1102345A (es)
DE (1) DE2854308A1 (es)
DK (1) DK534178A (es)
ES (1) ES476048A1 (es)
FR (1) FR2422624A1 (es)
GB (1) GB2010270B (es)
IE (1) IE48012B1 (es)
IT (1) IT1101735B (es)
NL (1) NL7812257A (es)
NO (1) NO148776C (es)
SE (1) SE436027B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (de) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim Heterocyclische verbindungen
JPS5993075A (ja) * 1982-11-18 1984-05-29 Shionogi & Co Ltd 1−フタリジル−5−フルオロウラシル誘導体の製造法
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (fr) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés .
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
EA019214B1 (ru) 2005-06-03 2014-02-28 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Способ лечения или профилактики заболеваний, вызванных дефицитом андрогенов у взрослых мужчин
CA2635335A1 (en) * 2005-12-30 2007-07-12 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
MX2010004789A (es) 2007-11-02 2010-07-05 Acrux Dds Pty Ltd Sistema de liberacion transdermica para hormonas y esteroides.
JP6621329B2 (ja) * 2012-10-05 2019-12-18 スファエラ ファーマ ピーティーイー リミテッド 新規化合物、それらの合成及びそれらの使用
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
CN110041264A (zh) * 2019-04-11 2019-07-23 贺州学院 一种金刚烷基咪唑类离子液体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (es) * 1955-03-19
BE798253A (nl) * 1973-04-16 1973-10-16 Bekaert Sa Nv Zitmeubel
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
FR2422624B1 (es) 1983-10-14
FR2422624A1 (fr) 1979-11-09
NO784229L (no) 1979-06-19
ATA901478A (de) 1981-08-15
AU4264678A (en) 1979-06-21
IE48012B1 (en) 1984-09-05
AT366380B (de) 1982-04-13
SE7812911L (sv) 1979-06-17
DK534178A (da) 1979-06-17
GB2010270A (en) 1979-06-27
IT7830735A0 (it) 1978-12-12
SE436027B (sv) 1984-11-05
DE2854308A1 (de) 1979-06-21
JPS5498711A (en) 1979-08-03
AU531835B2 (en) 1983-09-08
NO148776C (no) 1983-12-14
IE782499L (en) 1979-06-16
NL7812257A (nl) 1979-06-19
ES476048A1 (es) 1979-11-01
NO148776B (no) 1983-09-05
GB2010270B (en) 1982-10-20
CA1102345A (en) 1981-06-02
IT1101735B (it) 1985-10-07

Similar Documents

Publication Publication Date Title
ES505548A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
MX5950E (es) Procedimiento para la preparacion de derivados de la pirrolidin-2-ona
MX5527E (es) Procedimiento para la preparacion de derivados de carboestirilo
ES490214A0 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
AR222204A1 (es) Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES485620A0 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
AR221251A1 (es) Un procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
AR222478A1 (es) Un procedimiento para la preparacion de derivados de acetiloximetil-amonio cuaternario sustituidos
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES493579A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
MX5479E (es) Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas
AR222792A1 (es) Un procedimiento de preparacion de derivados de la tienopiridina
ES496487A0 (es) Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505556A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
AR218296A1 (es) Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
ES500381A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES489048A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES484890A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno